A 3% topical gel formulation of tenofovir disoproxil fumarate (TDF) for the treatment of human immunodeficiency virus (HIV) by experimental approach
DOI:
https://doi.org/10.12923/cipms-2026-0002Keywords:
ex vivo, Design-Expert®, tenofovir disoproxil fumarate, topical gel, spreadabilityAbstract
Tenofovir disoproxil fumarate (TDF) is widely used in the treatment of HIV-infected adults and is also approved for the management of chronic hepatitis B in adults, where it is administered in combination with other antiretroviral agents. The present study employed Design-Expert® software to investigate the effects of Kolliphor®P188 (g), Methocel®K100 Premium LV (g), and polyethylene glycol (mL) concentrations on the drug release characteristics of a topical TDF gel formulation. Eight formulations, including three center points, were prepared and evaluated for physical appearance, spreadability, syringibility, washability, pH, and ex vivo drug release. The interactions between formulation variables and drug release were also assessed. The results demonstrated statistically significant differences among formulations (p < 0.05). The findings indicate that polymer concentration is a critical formulation variable that must be carefully optimized to achieve a topical gel with desirable performance characteristics.
References
1. Martín-Illana A, Cazorla-Luna R, Notario-Pérez F, Rubio J, Ruiz-Caro R, Tamayo A, et al. Smart vaginal bilayer films of Tenofovir based on Eudragit® L100/natural polymer for the prevention of sexual transmission of HIV. Int J Pharm. 2021;602:120665. https://doi.org/10.1016/j.ijpharm.2021.120665
2. Martín-Illana A, Cazorla-Luna R, Notario-Pérez F, Rubio J, Ruiz-Caro R, Tamayo A, et al. Eudragit® L100/chitosan composite thin bilayer films for intravaginal pH-responsive release of Tenofovir. Int J Pharm. 2022;616:121554. https://doi.org/10.1016/j.ijpharm.2022.121554
3. Celum C, Baeten J. Tenofovir-based pre-exposure prophylaxis for HIV prevention: evidence and evolving questions. Curr Opin Infect Dis. 2012;25(1):51.
4. Ilomuanya MO, Hameedat AT, Akang EN, Ekama SO, Silva BO, Akanmu AS. Development and evaluation of mucoadhesive bigel containing tenofovir and maraviroc for HIV prophylaxis. Future J Pharm Sci. 2020;6(1):1-12.
5. Cautela MP, Moshe H, Sosnik A, Sarmento B, das Neves J. Composite films for vaginal delivery of tenofovir disoproxil fumarate and emtricitabine. Eur J Pharm Biopharm. 2019;138:3-10. https://doi.org/10.1016/j.ejpb.2018.02.001
6. Cazorla-Luna R, Martín-Illana A, Notario-Pérez F, Ruiz-Caro R, Tamayo A, Rubio J, et al. Development and in vitro/ex vivo characterization of vaginal mucoadhesive bilayer films based on ethylcellulose and biopolymers for vaginal sustained release of tenofovir. Biomacromolecules. 2020;21(6):2309-2319.
7. Johnson LM, Krovi SA, Li L, Girouard N, Demkovich ZR, Myers D, et al. Characterization of a reservoir-style implant for sustained release of tenofovir alafenamide (TAF) for HIV pre-exposure prophylaxis (PrEP). Pharmaceutics. 2019;11(7):315.
8. Notario-Pérez F, Cazorla-Luna R, Martín-Illana A, Ruiz-Caro R, Tamayo A, Rubio J, et al. Optimization of tenofovir release from mucoadhesive vaginal tablets by polymer combination to prevent sexual transmission of HIV. Carbohydr Polym. 2018;179:305-316.
9. Notario-Pérez F, Martín-Illana A, Cazorla-Luna R, Ruiz-Caro R, Peña J, Veiga MD. Improvement of tenofovir vaginal release from hydrophilic matrices through drug granulation with hydrophobic polymers. Eur J Pharm Sci. 2018;117:204-215.
10. Ham AS, Cost MR, Coleman JS, Jiang Y, Kizima L, Sykes C, et al. Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection. J Pharm Sci. 2012;101(4):1423-1435. https://doi.org/10.1002/jps.23026
11. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168-1174. https://doi.org/10.1126/science.1193748
12. Adams JL, Kashuba AD. Formulation, pharmacokinetics, and pharmacodynamics of topical microbicides. Best Pract Res Clin Obstet Gynaecol. 2012;26(4):451-462. https://doi.org/10.1016/j.bpobgyn.2012.01.004
13. Martín-Illana A, Chinarro E, Cazorla-Luna R, Notario-Pérez F, Veiga-Ochoa MD, Rubio J, et al. Optimized hydration dynamics in mucoadhesive xanthan-based trilayer vaginal films for the controlled release of tenofovir. Carbohydr Polym. 2022;278:118958.
14. Morteza-Semnani K, Saeedi M, Akbari J, Eghbali M, Babaei A, Hashemi SM, et al. Development of a novel nanoemulgel formulation containing cumin essential oil as skin permeation enhancer. Drug Deliv Transl Res. 2022;12(6):1455-1465.
15. Gunawardana M, Remedios-Chan M, Sanchez D, Webster S, Castonguay AE, Webster P, et al. Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis. Sci Rep. 2022;12:1-25.
16. Jayachandran P, Garcia-Cremades M, Vučićević K, Bumpus NN, Anton P, Hendrix C, et al. A mechanistic in vivo/ex vivo pharmacokinetic-pharmacodynamic model of tenofovir for HIV prevention. CPT Pharmacometrics Syst Pharmacol. 2021;10(3):179-187.
17. McGowan IM, Tzakis N, Kosak B, Korczak B, Engstrom J, Tomaszewska-Kiecana M, et al. Evaluation of the safety, acceptabi-lity, and pharmacokinetic profile of a gel formulation of OB-002 in healthy volunteers. AIDS Res Hum Retroviruses. 2021; 37(6):453-460.
18. Srivastava S, Mahor A, Singh G, Bansal K, Singh PP, Gupta R, et al. Formulation development, in vitro and in vivo evaluation of topical hydrogel formulation of econazole nitrate-loaded β-cyclodextrin nanosponges. J Pharm Sci. 2021;110(11):3702-3714.
19. Rapalli VK, Banerjee S, Khan S, Jha PN, Gupta G, Dua K, et al. QbD-driven formulation development and evaluation of topical hydrogel containing ketoconazole loaded cubosomes. Mater Sci Eng C. 2021;119:111548.
20. Fardous J, Omoso Y, Joshi A, Yoshida K, Patwary MK, Ono F, et al. Development and characterization of gel-in-water nanoemulsion as a novel drug delivery system. Mater Sci Eng C. 2021;124:112076.
21. Ismail TA, Shehata TM, Mohamed DI, Elsewedy HS, Soliman WE. Quality by design for development, optimization, and characterization of brucine ethosomal gel for skin cancer delivery. Molecules. 2021;26(11):3454.
22. Ch T, Madhuri S. Statistically 2 level factorial by Design Expert: in-vitro design and formulation of levetiracetam extended release tablets. Indian J Pharm Educ Res. 2022;56(4):1-8. https://doi.org/10.5530/ijper.54.2s.x
23. Taraka Ramarao C, Somireddy M. In-vitro design and formulation of levetiracetam extended release tablets. Res J Pharm Technol. 2022;15(8):3681-3684. https://doi.org/10.52711/0974-360X.2022.00617
24. Ramarao CHT, Srinivasa Rao B. Design and characterization of alfuzosin HCl gastroretentive floating matrix tablets employing HPMC K100M. Indian Drugs. 2018;55(11):71-73.
25. Ramarao CHT, Srinivasarao B, Vijayaratna J. Sustained release matrix tablets of diclofenac sodium employing Kollidon SR, PEG 6000, lactose monohydrate and Eudragit S100 in colon target. Indian Drugs. 2017;54(10):38-43.
26. Chowdary KPR, Ch T. A factorial study on the evaluation of formulation variables on the dissolution rate of etoricoxib tablets. Asian J Chem. 2011;23(3):958-960.
27. Taraka Ramarao C, et al. Applications of vaginal drug delivery: a review. Pharmacie Globale (IJCP). 2013;4(1):1-4.
28. KPR Chowdary, Rao CHT. Development and evaluation of irbesartan tablets: optimization by 22 factorial design. World J Pharm Res. 2014;5(2):1435-1443.
29. Ramarao CHT, Chowdary KPR, Rajeswara Rao P. Pharmacokinetic evaluation of optimized valsartan tablets formulated employing βCD, crospovidone and SLS in comparison to a market product. World J Pharm Pharm Sci. 2015;4(9):979-986.
30. Taraka Ramarao C, Chowdary KP, Rao PR. Formulation development of valsartan tablets: optimization by 2³ factorial design, in vitro and pharmacokinetic evaluation. World J Pharm Pharm Sci. 2015;4(9):979-986.
31. Murali B, Ramarao CHT. Strategic approaches and evaluation of gastro retentive drug delivery system—a review. NeuroQuantology. 2022;20(7):757-769. https://doi.org/10.14704/nq.2022.20.7.NQ33097
32. Challa TR, Reshma K. Experimental design statistically by Design Expert Software: a model poorly soluble drug with dissolution enhancement and optimization. Int J Drug Deliv Technol. 2022;12(3):1367-1375. https://doi.org/10.25258/ijddt.12.3.72
33. Ramarao CHT, Gunta P. Statistically optimization and formulation development of bromofenac sodium ophthalmic drug delivery. Suranaree J Sci Technol. 2022;29(6):070060(1-10).
34. Challa T, Yugandhar T. Design, formulation and evaluation of floating microspheres of timolol. World J Pharm Res. 2017;6(16):430-443.
35. Taraka Ramarao CH, Sravani P. Mucoadhesive microspheres of metoprolol succinate formulation and in vitro evaluation studies. Innooriginal Int J Sci. 2018;5(6):33-39.
36. Taraka Ramarao CH, Bhavyasri K. Formulation and evaluation of zidovudine floating tablets. World J Pharm Pharm Sci. 2018;7(8):1210-1220.
37. Ramarao CT, Rao BS, Ratna JV. Design of tinidazole matrix tablets for colon-specific drug delivery employing Eudragit S100, PEG 6000 and lactose. J Chem Pharm Res. 2018;10(1):76-82.
38. Taraka Ramarao C, Chowdary KPR, Rajeswara Rao P. In vitro and in vivo pharmacokinetic evaluation of valsartan tablets: optimization by factorial design 2³. Indian Drugs. 2020;57(11):15-21.
39. Ch T, Jami R. Formulation development of ezetimibe by using soluplus and co-processed acacia: tragacanth with Design Expert. Health Biotechnol Biopharma (HBB). 2022;6(3):33-56. https://doi.org/10.22034/HBB.2022.22
40. Challa TR, Akula K, Arasavilli K, Baratam M, Guntamukkala J, Malluri N, et al. Mirtazapine loaded solid and liquid self-emulsifying delivery system and characterization with neural network start (NNS) modelling. Palest Med Pharm J. 2025;10(1):Article 10. https://doi.org/10.59049/2790-0231.10.1.2277
41. Balijepalli MK, Patro CS, Ramarao CT. Formulation and optimization of floating sustained release tablets of atazanavir sulfate through Box-Behnken design. Asian J Pharm Clin Res. 2025;18(3):75-86. https://doi.org/10.22159/ajpcr.2025v18i3.53791
42. Ramarao CT, Laxmi SB. Floating drug delivery of sustained release antidepressant mirtazapine tablets by Box-Behnken design: formulation and optimization. Indian J Pharm Educ Res. 2024;58(1s):s113-s125. https://doi.org/10.5530/ijper.58.1s.11
43. Challa TR, Pathivada SK. Design and development of anti-inflammatory drug naproxen solid dispersions and formulations by factorial design approach. Suranaree J Sci Technol. 2023;30(6):070071(1-11). https://doi.org/10.55766/sujst-2023-06-e01216
44. Ramarao CT, Bammidi I, Banala M, Balaga K, Cheekati P, Busa Y. Assessment and validation of emulgel-based salicylic acid formulation development for drug release and optimisation by statistical design. Int J Comput Biol Drug Des. 2023;15(6):463-479. https://doi.org/10.1504/IJCBDD.2023.134615
45. Ramarao CT, Pavani P. Atorvastatin calcium formulation development followed by pharmacokinetic with in vitro and in vivo correlation (IVIVC) employing soluplus and hydroxypropyl methylcellulose with optimization. Egypt Pharm J. 2023;22(2):209-222. https://doi.org/10.4103/epj.epj_43_22
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Taraka Ramarao Challa, Manisha Kancharana, Ramakrishna Gunupuram, Raju Ejjada, Harshavardhan Gunna, Divya Dora (Autor)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
